Ajooni Biotech Live BSE/NSE | Ajooni Biotech Fundamenta data | Ajooni Biotech Balance sheet | Ajooni Biotech Quarterly Results | Ajooni Biotech Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

28.49
82.16
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

33.39
N/A
1.83

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales - 40 40 42 29 13 7 1 0 Net Sales Growth - 1% -6% 49% 116% 84% 1,165% 0 Cost Of Goods Sold - 35 36 38 24 11 6 0 0 Gross Profit - 5 3 5 4 2 1 0 0 GP Margin - 13% 8% 11% 15% 17% 19% 25% 0 Total Expenditure - 39 39 41 28 13 7 1 0 Power & Fuel Cost - 1 1 0 0 0 0 0 0 % Of Sales - 2% 1% 1% 0% 1% 1% 0% 0 Employee Cost - 1 1 1 1 0 0 0 0 % Of Sales - 3% 2% 2% 2% 3% 5% 7% 0 Manufacturing Exp. - 0 0 1 0 0 0 0 0 % Of Sales - 1% 0% 1% 0% 1% 2% 5% 0 General & Admin Exp. - 1 0 0 3 0 0 0 0 % Of Sales - 2% 1% 1% 10% 2% 1% 4% 0 Selling & Distn. Exp. - 1 1 1 0 1 1 0 0 % Of Sales - 3% 2% 3% 0% 8% 8% 5% 0 Miscellaneous Exp. - 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0 EBITDA - 1 1 1 1 0 0 0 0 EBITDA Margin - 3% 1% 2% 2% 2% 2% 2% 0 Other Income - 0 0 0 0 0 0 0 0 Interest - 0 0 0 0 0 0 0 0 Depreciation - 0 0 0 0 0 0 0 0 PBT - 0 0 0 0 0 0 0 0 Tax - 0 0 0 0 0 0 0 0 Tax Rate - 27% 13% 20% 28% 29% 27% 0% 0% PAT - 0 0 0 0 0 0 0 0 PAT before Minority Interest - 0 0 0 0 0 0 0 0 Minority Interest - 0 0 0 0 0 0 0 0 PAT Margin - 1% 1% 1% 1% 1% 1% 2% 0 PAT Growth - -15% 5% 39% 180% 43% 600% 0 EPS - 0.42 0.49 0.46 0.33 0.12 0.08 0.01 0.00

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Net Sales

Net Sales Growth

-6%

49%

116%

84%

1,165%

Cost Of Goods Sold

Gross Profit

GP Margin

13%

11%

15%

17%

19%

25%

Total Expenditure

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

% Of Sales

General & Admin Exp.

% Of Sales

10%

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

27%

13%

20%

28%

29%

27%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

PAT Growth

-15%

39%

180%

43%

600%

EPS

0.42

0.49

0.46

0.33

0.12

0.08

0.01

0.00

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 16 12 11 1 1 0 0 0 Share Capital 8 6 6 0 0 0 0 0 Total Reserves 7 6 5 1 0 0 0 0 Non-Current Liabilities 1 4 2 4 0 0 0 0 Secured Loans 0 0 0 1 0 0 0 0 Unsecured Loans 1 0 0 0 0 0 0 0 Long Term Provisions 0 0 0 0 0 0 0 0 Current Liabilities 6 2 6 8 2 1 0 0 Trade Payables 2 1 1 5 1 1 0 0 Other Current Liabilities 0 1 1 3 0 0 0 0 Short Term Borrowings 4 0 4 0 1 0 0 0 Short Term Provisions 0 0 0 0 0 0 0 0 Total Liabilities 23 18 19 13 2 2 0 0 Net Block 2 1 1 1 0 0 0 0 Gross Block 3 2 2 1 0 0 0 0 Accumulated Depreciation 1 1 1 0 0 0 0 0 Non Current Assets 5 6 8 7 0 0 0 0 Capital Work in Progress 0 0 0 0 0 0 0 0 Non Current Investment 3 4 6 6 0 0 0 0 Long Term Loans & Adv. 0 1 1 0 0 0 0 0 Other Non Current Assets 0 0 0 0 0 0 0 0 Current Assets 18 12 11 6 2 1 0 0 Current Investments 0 0 0 0 0 0 0 0 Inventories 3 5 2 4 0 0 0 0 Sundry Debtors 13 5 3 1 1 1 0 0 Cash & Bank 0 1 5 0 0 0 0 0 Other Current Assets 1 0 0 0 0 0 0 0 Short Term Loans & Adv. 1 1 1 0 0 0 0 0 Net Current Assets 12 10 5 -2 0 0 0 0 Total Assets 23 18 19 13 2 2 0 0

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Shareholder's Funds

Share Capital

Total Reserves

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

-2

Total Assets

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity -4 0 0 0 -1 0 0 0 PBT 0 0 0 0 0 0 0 0 Adjustment 1 0 0 0 0 0 0 0 Changes in Working Capital -6 0 0 0 -1 0 0 0 Cash after chg. in Working capital -4 0 0 0 -1 0 0 0 Interest Paid 0 0 0 0 0 0 0 0 Tax Paid 0 0 0 0 0 0 0 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 Cash From Investing Activity 0 0 0 0 0 0 0 0 Net Fixed Assets -1 0 0 -1 0 0 0 Net Investments 1 2 0 -6 0 0 0 Others 1 -2 1 7 0 0 0 Cash from Financing Activity 3 0 0 0 1 0 0 0 Net Cash Inflow / Outflow -1 0 0 0 0 0 0 0 Opening Cash & Equivalents 1 0 0 0 0 0 0 0 Closing Cash & Equivalent 0 0 0 0 0 0 0 0

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Cash From Operating Activity

-4

-1

PBT

Adjustment

Changes in Working Capital

-6

-1

Cash after chg. in Working capital

-4

-1

Interest Paid

Tax Paid

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

Net Fixed Assets

-1

Net Investments

-6

Others

-2

Cash from Financing Activity

Net Cash Inflow / Outflow

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 19 19 18 29 22 18 15 7 ROA 2% 2% 2% 4% 5% 7% 3% -14% ROE 3% 4% 7% 37% 20% 19% 4% -14% ROCE 4% 4% 10% 36% 19% 28% 7% -14% Fixed Asset Turnover 15.22 22.22 27.53 32.87 52.17 68.73 87.62 0.00 Receivable days 80 35 18 16 28 22 60 0 Inventory Days 38 32 27 30 11 13 109 0 Payable days 14 8 27 44 27 30 41 0 Cash Conversion Cycle 103 60 17 2 12 5 128 0 Total Debt/Equity 0.32 0.07 0.45 0.64 1.50 0.00 0.00 0.00 Interest Cover 2 5 2 4 8 63 20 0

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Book Value (Rs.)

ROA

-14%

ROE

37%

20%

19%

-14%

ROCE

10%

36%

19%

28%

-14%

Fixed Asset Turnover

15.22

22.22

27.53

32.87

52.17

68.73

87.62

0.00

Receivable days

Inventory Days

109

Payable days

Cash Conversion Cycle

103

128

Total Debt/Equity

0.32

0.07

0.45

0.64

1.50

0.00

Interest Cover

Ajooni Biotech Ltd.

Miscellaneous

BSE: Not Listed | NSE: AJOONI

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Ajooni Biotech Ltd.

Miscellaneous

BSE: Not Listed | NSE: AJOONI

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update